首页> 外文期刊>Experimental and clinical transplantation >Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells
【24h】

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells

机译:同基因CD4 + CD25 +调节性T细胞诱导的心脏同种异体移植耐受性

获取原文
           

摘要

Objectives: To evaluate the effect of isogeneic CD4+CD25+ regulatory T cells on cardiac allograft tolerance in heterotopic heart transplant from Balb/c to C57BL/6 mice. Materials and Methods: Isogeneic and allogeneic CD4+CD25+ regulatory T cells were obtained from pregnant C57BL/6 mice crossed with male Balb/c mice and from regular Balb/c mice. Recipient C57BL/6 mice were treated with sublethal radiation (2 Gy) and an infusion of isogeneic CD4+CD25+ regulatory T cells, allogeneic CD4+CD25+ regulatory T cells, or phosphate-buffered saline alone 1 day before a Balb/c-to-C57BL/6 heterotopic heart transplant. At 10 days after the transplant, cardiac allografts and the sera of recipients were evaluated with histology and cytokine analysis. Splenocytes of recipients were collected to determine chimerism on the day of the cessation of allograft heartbeat. Results: Mice that received an infusion of isogeneic CD4+CD25+ regulatory T cells had significantly greater mean median survival time, greater degree of chimerism, decreased levels of cytokines (monokine induced by interferon γ, interleukin 6, interleukin 10, and regulated upon activation, normal T cell expressed and secreted protein), and decreased lymphocytic infiltration than did mice that received phosphate-buffered saline alone. The effects on allograft tolerance were stronger in mice that received the isogeneic than the allogeneic CD4+CD25+ regulatory T cells. Conclusions : Isogeneic CD4+CD25+ regulatory T cells may establish cardiac allograft tolerance by inducing mixed chimerism and suppressing immune responses. Infusion with isogeneic CD4+CD25+ regulatory T cells combined with radiation (sublethal dose, 2 Gy) may establish allograft tolerance in mice. Therefore, further study is warranted because isogeneic CD4+CD25+ regulatory T cells may have therapeutic benefits.
机译:目的:评估同种CD4 + CD25 +调节性T细胞对Balb / c到C57BL / 6小鼠异位心脏移植心脏异体移植耐受的影响。材料和方法:同种和同种CD4 + CD25 +调节性T细胞是从与雄性Balb / c小鼠杂交的怀孕C57BL / 6小鼠和常规Balb / c小鼠获得的。在接受Balb / c-to-to-to-c攻击前1天,分别用亚致死辐射(2 Gy)和同种CD4 + CD25 +调节性T细胞,同种CD4 + CD25 +调节性T细胞或磷酸盐缓冲液单独处理接受的C57BL / 6小鼠。 C57BL / 6异位心脏移植。移植后第10天,通过组织学和细胞因子分析评估心脏同种异体移植物和受体血清。收集受体的脾细胞以确定同种异体移植心跳停止当天的嵌合状态。结果:输注同种CD4 + CD25 +调节性T细胞的小鼠平均中位生存时间明显更长,嵌合程度更高,细胞因子水平降低(干扰素γ诱导的单核细胞因子,白介素6,白介素10以及激活后受到调节,正常的T细胞表达和分泌蛋白质),并且比仅接受磷酸盐缓冲盐水的小鼠减少了淋巴细胞浸润。同种小鼠比同种CD4 + CD25 +调节性T细胞对同种异体移植耐受性的影响更强。结论:同基因CD4 + CD25 +调节性T细胞可能通过诱导混合嵌合体和抑制免疫应答而建立心脏同种异体移植耐受性。输注同种CD4 + CD25 +调节性T细胞并结合放射线(亚致死剂量,2 Gy)可在小鼠体内建立同种异体移植耐受性。因此,有必要进行进一步的研究,因为同质CD4 + CD25 +调节性T细胞可能具有治疗益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号